StopAfib.org founder Mellanie True Hills will be speaking at the Sixth Annual Western Atrial Fibrillation Symposium about how healthcare professionals can engage their afib patients to get optimal results for both. If you’re a healthcare professional, there is still time to register. If you’re a patient, please share your experiences with Mellanie. Learn more at …
Read More
In this video interview, Dr. Wilber Su discusses what he has learned from doing more than 600 cryoballoon ablations as well as about 50 hybrid procedures. To watch the video or read the transcript, see: Cryo Balloon Ablation for Atrial Fibrillation — Video Interview with Dr. Wilber Su
Read More
As we started 2013, and reflected on how blessed we were to touch the lives of so many in 2012, we received two messages almost simultaneously that really touched our hearts and made us realize that we should be sharing these messages. We frequently receive kind and thoughtful messages from folks who have found solutions …
Read More
Press Release: Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS® (apixaban) Friday, December 28, 2012 5:46 pm EST PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved ELIQUIS® (apixaban). Please see full Prescribing Information including BOXED WARNING and Medication Guide …
Read More
StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Videos of 2012. This year the FIRM ablation interviews with Dr. Narayan topped the list. Other popular topics included stroke prevention, new afib guidelines, sleep apnea, and medications. Stories about efficacy of catheter ablation and surgical procedures, comparisons of rate and rhythm control, and other …
Read More
Good to see the FDA moving on this as we're starting to hear of afib patients with mechanical heart valves getting Pradaxa. Here is the FDA announcement... ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the blood thinner (anticoagulant) Pradaxa (dabigatran etexilate mesylate) should not be used …
Read More
StopAfib.org is pleased to unveil the Top Ten Atrial Fibrillation Articles of 2012. There were many topics of interest this year to the atrial fibrillation patient community. As always, the top interest was atrial fibrillation stroke prevention — that included the CHADS2 and CHA2DS2-VASc scoring tools that determine the need for anticoagulants, the HAS-BLED tool …
Read More
StopAfib.org has joined the Fair Access to Cardiac Technology (FACT) Alliance to raise awareness of the importance of access to this medical technology for the detection of atrial fibrillation and other arrhythmias. The FACT Alliance has started a petition to ensure that everyone has access to this potentially life-saving Mobile Cardiac Telemetry (MCT) technology. Learn …
Read More
The Alliance for Aging Research and the AFib Optimal Treatment Task Force have released a new survey that found that atrial fibrillation patients are active in the decision-making process regarding their treatment. Learn more and access the survey reports at: Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in …
Read More
Recently, StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to ask questions of three of their atrial fibrillation experts, Dr. Walid Saliba, Dr. Sergio Pinski, and Dr. David Van Wagoner, along with StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts from the Cleveland …
Read More